STEPHEN MERRELL: Open Payments
NPI 1003174129 · FARMINGTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 45 payments from 17 companies in 2025. Trend: 2023 $1,196 · 2024 $1,142 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $131 |
| GlaxoSmithKline, LLC. | 5 | $78 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| PFIZER INC. | 3 | $59 |
| Lilly USA, LLC | 3 | $49 |
| bioMerieux Inc | 1 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Novo Nordisk Inc | 2 | $39 |
| Organon LLC | 2 | $26 |
Products named: JARDIANCE, QULIPTA, VRAYLAR, UBRELVY, MOUNJARO, SHINGRIX, BIOFIRE SPOTFIRE Control Station, Sunosi.
Industry payments across UT — which companies pay providers there.
